SOFT TISSUE SARCOMAS

Clinical trials for SOFT TISSUE SARCOMAS explained in plain language.

Never miss a new study

Get alerted when new SOFT TISSUE SARCOMAS trials appear

Sign up with your email to follow new studies for SOFT TISSUE SARCOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New cocktail of four drugs targets tough sarcomas in kids

Disease control Not yet recruiting

This early-phase trial tests a combination of four drugs—pazopanib, trabectedin, ipilimumab, and nivolumab—in children and young adults up to age 30 whose soft tissue sarcomas have come back. The goal is to see if adding pazopanib to the existing three-drug regimen is safe and he…

Matched conditions: SOFT TISSUE SARCOMAS

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 09:09 UTC

SOFT TISSUE SARCOMAS

Get alerted when new SOFT TISSUE SARCOMAS trials appear

New cocktail of four drugs targets tough sarcomas in kids